Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialAlfons JM van den Eertwegh, Winald R. Gerritsen, Jurjen Versluis et al.|The Lancet Oncology|2012Cited by 357
A Clinical Development Paradigm for Cancer Vaccines and Related BiologicsAxel Hoos, Geoffrey Nichol, Hans Loibner et al.|Journal of Immunotherapy|2006Cited by 271